Blood clot risk high following COVID-19 hospitalization
(HealthDay)—Following COVID-19 hospitalization, thromboembolic events occur frequently, according to a study published online April 6 in Blood. Dimitrios Giannis, M.D., […]
The US Food and Drug Administration has declared Medtronic’s recall of seven models of defibrillating cardiac rhythm devices, due to […] A new source of energy expending brown fat cells has been uncovered by researchers at the Joslin Diabetes Center, which […] Shivrat Chhabra is CEO of Dosis, a company that offers an artificial intelligence-powered personalized dosing platform used by dialysis providers […] A digitally supported psychological reasoning intervention known as SlowMo helps patients with persistent paranoia “slow down” their thinking to curb […] Microsoft on Monday announced that it will acquire Nuance Communications, a deal aimed largely at advancing cloud and artificial intelligence […] Besides their social media empire and their famous Keeping Up with The Kardashians reality show, the Kardashians are nothing more […] The risk of being infected with the coronavirus indoors can now be determined more reliably than before using a web […] To celebrate the launch of Kayla Itsines’ new Low-Impact Program, the SWEAT app fitness trainer has shared a snipped from […] The COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) has reviewed reports of rare cases of […]Health News
Medtronic Recall of Almost 240,000 ICDs Is Class I, FDA Says
Pain receptors linked to the generation of energy-burning brown fat cells
AI-powered precision drug dosing can boost outcomes and cost efficiency
‘SlowMo’ Therapy Offers ‘Freedom and Peace’ From Paranoia
Microsoft to acquire Nuance for almost $20 billion
Weight Loss Secrets Of The Kardashians – No Wonder They Keep Looking Fit & Fabulous
New app calculates coronavirus infection risk in rooms
Kayla Itsines' Low Intensity Upper Body Workout Will Take Under 15mins of Your Time
GACVS COVID-19 reviews rare cases of blood clots following AstraZeneca COVID-19 vaccination